Search Results - "Baronzio, Gianfranco"
-
1
Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report
Published in Investigational new drugs (01-02-2012)“…Summary Altered metabolism of cancer first highlighted by Otto Warburg has a long history. Although ignored for a considerable amount of time, it is now…”
Get full text
Journal Article -
2
Hyperthermia and Immunity. A Brief Overview
Published in In vivo (Athens) (01-11-2006)“…After many years, hyperthermia (HT) is experiencing a new resurgence as seen by the positive results of many randomized trials all over the world. Tumour…”
Get full text
Journal Article -
3
Current Role and Future Perspectives of Hyperthermia for Prostate Cancer Treatment
Published in In vivo (Athens) (01-01-2009)“…Prostate cancer is the second most common cause of death in men. Between 10% -60% of patients experience biochemical recurrence associated with treatment…”
Get full text
Journal Article -
4
Update on the challenges and recent advances in cancer immunotherapy
Published in ImmunoTargets and therapy (01-01-2013)“…This overview provides an analysis of some of the immunotherapies currently in use and under investigation, with a special focus on the tumor microenvironment,…”
Get full text
Journal Article -
5
Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid
Published in Frontiers in oncology (23-07-2015)“…Every drug used to treat cancer (chemotherapeutics, immunological, monoclonal antibodies, nanoparticles, radionuclides) must reach the targeted cells through…”
Get full text
Journal Article -
6
Tumor interstitial fluid: proteomic determination as a possible source of biomarkers
Published in Cancer genomics & proteomics (01-09-2014)“…Tumor interstitial fluid (TIF) is formed largely by an imbalance between the forces that govern the filtration of liquid between the luminal and abluminal…”
Get full text
Journal Article -
7
Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis
Published in Anticancer research (01-02-2012)“…Tumor interstitial fluid (TIF) is a watery phase that accumulates inside the tumor interstitium. Its genesis and fate depend on various factors, namely tumor…”
Get full text
Journal Article -
8
Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin
Published in Investigational new drugs (01-04-2013)“…Summary Cellular metabolic alterations are now well described as implicated in cancer and some strategies are currently developed to target these different…”
Get full text
Journal Article -
9
Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice
Published in Investigational new drugs (01-08-2012)“…Summary Alterations in metabolic pathways are known to characterize cancer. In order to suppress cancer growth, however, multiple proteins involved in these…”
Get full text
Journal Article -
10
Review. Current role and future perspectives of hyperthermia for prostate cancer treatment
Published in In vivo (Athens) (01-01-2009)“…Prostate cancer is the second most common cause of death in men. Between 10%-60% of patients experience biochemical recurrence associated with treatment…”
Get full text
Journal Article -
11
Is it necessary to deplete the lymphokine activated killers’ populations of CD4+CD25+ lymphocytes? Regulatory Foxp3-positive T cells within lymphokine activated killers
Published in Biomedicine & pharmacotherapy (01-07-2010)“…Abstract LAKs are used in cancer therapy. A common argument against LAK therapy is the probability of the activation of Tregs by IL-2 alongside with NK cells…”
Get full text
Journal Article -
12
Tumor Interstitial Fluid as Modulator of Cancer Inflammation, Thrombosis, Immunity and Angiogenesis
Published in Anticancer research (2012)Get full text
Journal Article -
13
Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/[beta]-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers
Published in ISRN oncology (01-01-2011)“…Nanocomposition comprised of interleukin-2 in suboptimal noneffective concentration and β-cyclodextrin was studied in vitro. This preparation as well as…”
Get full text
Journal Article -
14
Tumor microenvironment and hemorheological abnormalities
Published in Seminars in thrombosis and hemostasis (01-10-2003)“…This article reviews the various mechanisms in a malignant tumor that lead to hypoxia, production of tumor interstitial fluid, and rheological changes in its…”
Get more information
Journal Article -
15
-
16
Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers
Published in ISRN oncology (01-01-2011)“…Nanocomposition comprised of interleukin-2 in suboptimal noneffective concentration and β-cyclodextrin was studied in vitro. This preparation as well as…”
Get full text
Journal Article -
17
Stem cell recruitment and liver de-differentiation in MMTV-neu (ErbB-2) transgenic mice
Published in Anticancer research (01-09-2003)“…The liver of tumor-bearing hosts manifests fetal phenotypes. We investigated the expression of differentiation markers on the liver in MMTV-neu (ErbB-2)…”
Get more information
Journal Article -
18
Proinflammatory and regulatory cytokine levels in AIDS cachexia
Published in In vivo (Athens) (01-11-1999)“…The serum concentrations of inflammatory (Interleukin-1 beta, Tumor necrosis alpha, Interleukin-6) and regulatory cytokines (Interleukin twelve) have been…”
Get more information
Journal Article